相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
Patricia Guyot et al.
BMC MEDICAL RESEARCH METHODOLOGY (2012)
Meta-analysis of effect sizes reported at multiple time points: A multivariate approach
Thomas A. Trikalinos et al.
CLINICAL TRIALS (2012)
Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study
Lihui Zhao et al.
CLINICAL TRIALS (2012)
Statistical Analysis of Individual Participant Data Meta-Analyses: A Comparison of Methods and Recommendations for Practice
Gavin B. Stewart et al.
PLOS ONE (2012)
Two-stage meta-analysis of survival data from individual participants using percentile ratios
Jessica K. Barrett et al.
STATISTICS IN MEDICINE (2012)
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Timothy J. Perren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt
Patrick Royston et al.
STATISTICS IN MEDICINE (2011)
Individual patient data meta-analysis of time-to-event outcomes: one-stage versus two-stage approaches for estimating the hazard ratio under a random effects model
Jack Bowden et al.
RESEARCH SYNTHESIS METHODS (2011)
Meta-analysis of time-to-event data: a comparison of two-stage methods
Mark C. Simmonds et al.
RESEARCH SYNTHESIS METHODS (2011)
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
A. Auperin et al.
LANCET (2010)
Pseudo-observations in survival analysis
Per Kragh Andersen et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2010)
One-stage parametric meta-analysis of time-to-event outcomes
F. Siannis et al.
STATISTICS IN MEDICINE (2010)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Meta-analysis of pairs of survival curves under heterogeneity: A Poisson correlated gamma-frailty approach
M. Fiocco et al.
STATISTICS IN MEDICINE (2009)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
Jean-Yves Douillard et al.
LANCET ONCOLOGY (2006)
Neoadjuvant chemotherapy in invasive bladder cancer:: Update of a systematic review and meta-analysis of individual patient data
H Abol-Enein et al.
EUROPEAN UROLOGY (2005)
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer
T Winton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Postoperative adjuvant chemotherapy for stage I non-smatt cell lung cancer
JH Park et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2005)
Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes
CT Smith et al.
STATISTICS IN MEDICINE (2005)
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice
MC Simmonds et al.
CLINICAL TRIALS (2005)
A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data
PF Moodie et al.
STATISTICS IN MEDICINE (2004)
A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304)
H Tada et al.
LUNG CANCER (2004)
Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial
D Waller et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2004)
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer
GV Scagliotti et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
HB Grossman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Aggregate data meta-analysis with time-to-event outcomes
PR Williamson et al.
STATISTICS IN MEDICINE (2002)
Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours
L Sengelov et al.
ACTA ONCOLOGICA (2002)
Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects
P Royston et al.
STATISTICS IN MEDICINE (2002)
Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer - Nordic cystectomy trial 2
A Sherif et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2002)
Postoperative adjuvant therapy for stage IB non-small-cell lung cancer
TC Mineo et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2001)
分享论文
